Pontus Protein WKN: A2QNFB ISIN: CA7327681069 Kürzel: HULK Forum: Aktien Thema: Hauptdiskussion

nein ich glaube die Fertigstellung der Anlage ist noch offen. die brauchen wiederholt frische Kapitalspritzen zur Erreichung der nächsten Meilensteine. aus meiner Sicht ist die Fertigstellung der Anlage das kleinste Problem. es folgen vermutlich einige magere Jahre wo sie tiefrote Zahlen schreiben, was aber bei Startups normal ist. ich bleibe an der Seitenlinie bis ich in einem künftigen Jahresbericht tatsächliche Umsätze sehe, die durch den Verkauf der Produkte generiert werden. das wird ein ziemlich schwerer Meilenstein sein, aber machbar wenn sie das Projekt gut managen. Von ihrer bisherigen Leistung war ich leider nicht beeindruckt. Ich war anfangs auch ein Fan, aber jetzt bin ich skeptisch.

Vielen Dank für die Ausführung... Ich will seit Wochen nur noch raus .. Mal sehen wie weit es Dienstag runtergeht 🙈🙈🙈

Ist die Anlage denn fertig und produziert?

PONTUS PROTEIN ANNOUNCES REINSTATEMENT OF TRADING ON THE TSX VENTURE EXCHANGE VANCOUVER, B.C., June 17, 2022. Pontus Protein Ltd. (TSXV: HULK, OTCQB: HLKKF, FSE: 8YC) (“Pontus” or the “Company”) is pleased to announce that the TSX Venture Exchange (the “Exchange”) has conducted its reinstatement review of trading of the Company’s common shares (the “Shares”). Reinstatement of trading of the Shares on the Exchange is expected to take place on Tuesday, June 21, 2022. Trading of the Shares was suspended by the Exchange as a result of the Company’s principal regulator, the British Columbia Commission (the “BCSC”), issuing a Cease Trade Order (the “CTO”) in resect of the Company’s failure to file its audited annual financial statements for the year ended November 30, 2021, related management’s discussion and analysis and officer certifications (collectively, the “Annual Filings”) by March 30, 2022. The Company filed the Annual Filings, following which the BCSC subsequently revoked the CTO on May 3, 2022. In addition, further to the news release dated June 14, 2022, the Company wishes to announce that Mr. David Bentil has been appointed to the Audit Committee of the Company. The Audit Committee, as of the date hereof, comprises of Mr. Bentil, Mr. David Jenkins and Mr. Mohsen Rahimi. Mr. Bentil shall also serve as Chair of the Audit Committee. About Pontus Protein Ltd. This is our future – the future of farming; Pontus Protein Ltd. is a Vancouver-based agricultural food and technology company focused on creating and acquiring the best technology. Highly sophisticated, AI-engineered robots, combined with our proprietary vertical farming and a commitment to sustainability. Our intellectual property optimizes efficiency for a shorter growing time and high productivity. We deliver healthy, affordable foods and nutrients into every diet in a closed, controlled environment avoiding all pesticides and GMOs. Pontus Protein is publicly traded in Canada (TSXV:HULK), the United States (OTCQB: HLKKF) and Germany (FSE: 8YC) and you can find out more on our SEDAR profile. Learn more about Pontus: Website | Investor Page | LinkedIn | YouTube | Twitter On behalf of the Board of Directors “Avtar Dhaliwal” Avtar Dhaliwal, CEO Pontus Protein Ltd.